Editas Medicine, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ALLO
Allogene Therapeutics, Inc. |
$2.21 | $484.38 M | -1.3 | 232 | $95,000 |
BEAM
Beam Therapeutics Inc. |
$26.58 | $1.91 B | -14.51 | 472 | $377.71 M |
CRBU
Caribou Biosciences, Inc. |
$1.66 | $176.12 M | -1.41 | 158 | $34.48 M |
CRSP
CRISPR Therapeutics AG |
$40.02 | $4.91 B | -21.43 | 407 | $371.21 M |
DNA
Ginkgo Bioworks Holdings, Inc. |
$9.66 | $1.14 B | -1.2 | 1218 | $251.46 M |
NTLA
Intellia Therapeutics, Inc. |
$11.98 | $2.19 B | -4.23 | 526 | $36.28 M |
PRME
Prime Medicine, Inc. |
$2.91 | $788.60 M | -3.01 | 234 | $0 |
SANA
Sana Biotechnology, Inc. |
$1.61 | $1.55 B | -4.59 | 328 | $0 |
VERV
Verve Therapeutics, Inc. |
$6.01 | $409.24 M | -1.82 | 255 | $11.76 M |
VRTX
Vertex Pharmaceuticals Incorporated |
$408.70 | $124.65 B | 31.39 | 5400 | $9.87 B |